Cargando…

Separate Gut Plasma Cell Populations Produce Auto‐Antibodies against Transglutaminase 2 and Transglutaminase 3 in Dermatitis Herpetiformis

Dermatitis herpetiformis (DH) is an inflammatory skin disorder often considered as an extra intestinal manifestation of celiac disease (CeD). Hallmarks of CeD and DH are auto‐antibodies to transglutaminase 2 (TG2) and transglutaminase 3 (TG3), respectively. DH patients have auto‐antibodies reactive...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Saykat, Stamnaes, Jorunn, Kemppainen, Esko, Hervonen, Kaisa, Lundin, Knut E. A., Parmar, Naveen, Jahnsen, Frode L., Jahnsen, Jørgen, Lindfors, Katri, Salmi, Teea, Iversen, Rasmus, Sollid, Ludvig M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477854/
https://www.ncbi.nlm.nih.gov/pubmed/37424036
http://dx.doi.org/10.1002/advs.202300401
_version_ 1785101224281899008
author Das, Saykat
Stamnaes, Jorunn
Kemppainen, Esko
Hervonen, Kaisa
Lundin, Knut E. A.
Parmar, Naveen
Jahnsen, Frode L.
Jahnsen, Jørgen
Lindfors, Katri
Salmi, Teea
Iversen, Rasmus
Sollid, Ludvig M.
author_facet Das, Saykat
Stamnaes, Jorunn
Kemppainen, Esko
Hervonen, Kaisa
Lundin, Knut E. A.
Parmar, Naveen
Jahnsen, Frode L.
Jahnsen, Jørgen
Lindfors, Katri
Salmi, Teea
Iversen, Rasmus
Sollid, Ludvig M.
author_sort Das, Saykat
collection PubMed
description Dermatitis herpetiformis (DH) is an inflammatory skin disorder often considered as an extra intestinal manifestation of celiac disease (CeD). Hallmarks of CeD and DH are auto‐antibodies to transglutaminase 2 (TG2) and transglutaminase 3 (TG3), respectively. DH patients have auto‐antibodies reactive with both transglutaminase enzymes. Here it is reported that in DH both gut plasma cells and serum auto‐antibodies are specific for either TG2 or TG3 with no TG2–TG3 cross reactivity. By generating monoclonal antibodies from TG3‐specific duodenal plasma cells of DH patients, three conformational epitope groups are defined. Both TG2‐specific and TG3‐specific gut plasma cells have few immunoglobulin (Ig) mutations, and the two transglutaminase‐reactive populations show distinct selection of certain heavy and light chain V‐genes. Mass spectrometry analysis of TG3‐specific serum IgA corroborates preferential usage of IGHV2‐5 in combination with IGKV4‐1. Collectively, these results demonstrate parallel induction of anti‐TG2 and anti‐TG3 auto‐antibody responses involving separate B‐cell populations in DH patients.
format Online
Article
Text
id pubmed-10477854
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-104778542023-09-06 Separate Gut Plasma Cell Populations Produce Auto‐Antibodies against Transglutaminase 2 and Transglutaminase 3 in Dermatitis Herpetiformis Das, Saykat Stamnaes, Jorunn Kemppainen, Esko Hervonen, Kaisa Lundin, Knut E. A. Parmar, Naveen Jahnsen, Frode L. Jahnsen, Jørgen Lindfors, Katri Salmi, Teea Iversen, Rasmus Sollid, Ludvig M. Adv Sci (Weinh) Research Articles Dermatitis herpetiformis (DH) is an inflammatory skin disorder often considered as an extra intestinal manifestation of celiac disease (CeD). Hallmarks of CeD and DH are auto‐antibodies to transglutaminase 2 (TG2) and transglutaminase 3 (TG3), respectively. DH patients have auto‐antibodies reactive with both transglutaminase enzymes. Here it is reported that in DH both gut plasma cells and serum auto‐antibodies are specific for either TG2 or TG3 with no TG2–TG3 cross reactivity. By generating monoclonal antibodies from TG3‐specific duodenal plasma cells of DH patients, three conformational epitope groups are defined. Both TG2‐specific and TG3‐specific gut plasma cells have few immunoglobulin (Ig) mutations, and the two transglutaminase‐reactive populations show distinct selection of certain heavy and light chain V‐genes. Mass spectrometry analysis of TG3‐specific serum IgA corroborates preferential usage of IGHV2‐5 in combination with IGKV4‐1. Collectively, these results demonstrate parallel induction of anti‐TG2 and anti‐TG3 auto‐antibody responses involving separate B‐cell populations in DH patients. John Wiley and Sons Inc. 2023-07-09 /pmc/articles/PMC10477854/ /pubmed/37424036 http://dx.doi.org/10.1002/advs.202300401 Text en © 2023 The Authors. Advanced Science published by Wiley‐VCH GmbH https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Das, Saykat
Stamnaes, Jorunn
Kemppainen, Esko
Hervonen, Kaisa
Lundin, Knut E. A.
Parmar, Naveen
Jahnsen, Frode L.
Jahnsen, Jørgen
Lindfors, Katri
Salmi, Teea
Iversen, Rasmus
Sollid, Ludvig M.
Separate Gut Plasma Cell Populations Produce Auto‐Antibodies against Transglutaminase 2 and Transglutaminase 3 in Dermatitis Herpetiformis
title Separate Gut Plasma Cell Populations Produce Auto‐Antibodies against Transglutaminase 2 and Transglutaminase 3 in Dermatitis Herpetiformis
title_full Separate Gut Plasma Cell Populations Produce Auto‐Antibodies against Transglutaminase 2 and Transglutaminase 3 in Dermatitis Herpetiformis
title_fullStr Separate Gut Plasma Cell Populations Produce Auto‐Antibodies against Transglutaminase 2 and Transglutaminase 3 in Dermatitis Herpetiformis
title_full_unstemmed Separate Gut Plasma Cell Populations Produce Auto‐Antibodies against Transglutaminase 2 and Transglutaminase 3 in Dermatitis Herpetiformis
title_short Separate Gut Plasma Cell Populations Produce Auto‐Antibodies against Transglutaminase 2 and Transglutaminase 3 in Dermatitis Herpetiformis
title_sort separate gut plasma cell populations produce auto‐antibodies against transglutaminase 2 and transglutaminase 3 in dermatitis herpetiformis
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477854/
https://www.ncbi.nlm.nih.gov/pubmed/37424036
http://dx.doi.org/10.1002/advs.202300401
work_keys_str_mv AT dassaykat separategutplasmacellpopulationsproduceautoantibodiesagainsttransglutaminase2andtransglutaminase3indermatitisherpetiformis
AT stamnaesjorunn separategutplasmacellpopulationsproduceautoantibodiesagainsttransglutaminase2andtransglutaminase3indermatitisherpetiformis
AT kemppainenesko separategutplasmacellpopulationsproduceautoantibodiesagainsttransglutaminase2andtransglutaminase3indermatitisherpetiformis
AT hervonenkaisa separategutplasmacellpopulationsproduceautoantibodiesagainsttransglutaminase2andtransglutaminase3indermatitisherpetiformis
AT lundinknutea separategutplasmacellpopulationsproduceautoantibodiesagainsttransglutaminase2andtransglutaminase3indermatitisherpetiformis
AT parmarnaveen separategutplasmacellpopulationsproduceautoantibodiesagainsttransglutaminase2andtransglutaminase3indermatitisherpetiformis
AT jahnsenfrodel separategutplasmacellpopulationsproduceautoantibodiesagainsttransglutaminase2andtransglutaminase3indermatitisherpetiformis
AT jahnsenjørgen separategutplasmacellpopulationsproduceautoantibodiesagainsttransglutaminase2andtransglutaminase3indermatitisherpetiformis
AT lindforskatri separategutplasmacellpopulationsproduceautoantibodiesagainsttransglutaminase2andtransglutaminase3indermatitisherpetiformis
AT salmiteea separategutplasmacellpopulationsproduceautoantibodiesagainsttransglutaminase2andtransglutaminase3indermatitisherpetiformis
AT iversenrasmus separategutplasmacellpopulationsproduceautoantibodiesagainsttransglutaminase2andtransglutaminase3indermatitisherpetiformis
AT sollidludvigm separategutplasmacellpopulationsproduceautoantibodiesagainsttransglutaminase2andtransglutaminase3indermatitisherpetiformis